首页> 外文期刊>Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology >Identification of a Novel MYH9 Mutation in a Young Adult With Inherited Thrombocytopenia and Recurrent Seizures by Targeted Exome Sequencing
【24h】

Identification of a Novel MYH9 Mutation in a Young Adult With Inherited Thrombocytopenia and Recurrent Seizures by Targeted Exome Sequencing

机译:靶向外壳测序鉴定青少年血小阴十叶血小阴盆遗传血小阴盆和复发癫痫发作的新型MYH9突变

获取原文
获取原文并翻译 | 示例
       

摘要

May-Hegglin anomaly (MHA) is a rare autosomal dominant disorder caused by a mutation in the myosin heavy chain 9 ( MYH9 ) gene. MHA patients have variable clinical manifestations including thrombocytopenia, renal injury, hearing impairment, and cataracts. We describe a 25-year-old man with isolated thrombocytopenia initially. He experienced recurrent seizures with stable thrombocytopenia after the first seizures related to intracranial hemorrhage. He was identified a novel c.3452C>T mutation by targeted exome sequencing. If a patient with thrombocytopenia shows recurrent seizures as well as renal, hearing, visual symptoms, MHA should be suspected and the targeted exome sequencing is considered an effective diagnostic tool.
机译:May-Hegglin异常(MHA)是一种稀有的炎常规显性紊乱,由肌球蛋白重链9(MYH9)基因的突变引起。 MHA患者具有可变的临床表现,包括血小板减少症,肾损伤,听力障碍和白内障。 最初,我们描述了一个25岁的男子,血小板减少血小阴蛋白。 在与颅内出血相关的第一次癫痫发作后,他经常使用稳定的血小板减少症进行复发癫痫发作。 他通过靶向外壳测序确定了一种新的C.3452C> T突变。 如果患有血小板减少症的患者显示复发性癫痫发作以及肾,听力,视觉症状,应怀疑MHA,并且靶向外序列测序被认为是有效的诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号